Tetraphase Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Tetraphase Pharmaceuticals Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Tetraphase Pharmaceuticals Inc Strategy Report

  • Understand Tetraphase Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Tetraphase Pharmaceuticals Inc: Overview

Select Item

Tetraphase Pharmaceuticals Inc (Tetraphase), a subsidiary of La Jolla Pharmaceutical Company, is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include Xerava (eravacycline), TP-271, TP-2846 and TP-6076. It develops products for the treatment of respiratory diseases caused by bacterial biothreat and antibiotic-resistant public health pathogens. Tetraphase’s eravacycline is used for the treatment of multi-drug resistant (MDR) infections which include MDR gram-negative bacteria. The company offers drugs in therapeutic areas of antibiotics, oncology and inflammatory diseases. It also offers research and the creation of tetracycline drugs. Tetraphase is headquartered in Waltham, Massachusetts, the US.

 Gain a 360-degree view of Tetraphase Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Tetraphase Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address Suite 400, 201 Jones Road, Waltham, Massachusetts, 02451
Website www.tphase.com
Telephone 1 617 7153600
No of Employees 67
Industry Pharmaceuticals and Healthcare
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Tetraphase Pharmaceuticals Inc premium industry data and analytics

30+

Clinical Trials

Determine Tetraphase Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

12+

Pipeline Drugs

Identify which of Tetraphase Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

Catalyst Calendar

Proactively evaluate Tetraphase Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Sales & Consensus Forecasts

Understand the current and future drug revenue for Tetraphase Pharmaceuticals Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Marketed Drugs

Understand Tetraphase Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Tetraphase Pharmaceuticals Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Commercial:
Xerava - for complicated intra-abdominal infections (cIAI).
Pipeline
XYZ
XYZ
XYZ
Understand Tetraphase Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Tetraphase Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Tetraphase Pharmaceuticals Inc Humanigen Inc CorMedix Inc Allergan Inc
Headquarters United States of America United States of America United States of America Canada
City Waltham Short Hills Berkeley Heights Markham
State/Province Massachusetts New Jersey New Jersey Ontario
No. of Employees 67 6 40 -
Entity Type Private Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Leonard Patrick Gage, Ph.D. Chairman Executive Board 2011 78
Larry Edwards Director; Chief Executive Officer; President Executive Board 2019 49
Maria Stahl Chief Business Officer Senior Management 2019 50
Guy Macdonald Director Executive Board 2008 62
Christopher Watt Senior Vice President - Finance Senior Management 2017 56
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into Tetraphase Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Tetraphase Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward